Lv13
90 积分 2024-10-17 加入
Case Study #1: Alpha Particle Therapy of Leukemia Using 225Ac-Lintuzumab
3小时前
已完结
Abstract 4303: AZD2284: A novel, alpha-particle emitting radioconjugate targeting STEAP2 in metastatic castration-resistant prostate cancer
8天前
已关闭
Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin αvβ3
9天前
已完结
Synthesis and preclinical evaluation of a heterodimeric radioligand targeting fibroblast activation protein and integrin-αvβ3
9天前
已完结
Novel approaches for detection and targeted therapy of prostate cancer using antibodies, aptamers, and nanobodies
9天前
已完结
Abstract 1822: Preclinical efficacy and safety of CS5008, a novel SSTR2×DLL3 bispecific antibody-drug conjugate (ADC) with topoisomerase 1 inhibitor payload for small cell lung cancer and neuroendocrine tumors
9天前
已关闭
Therapy strategies to defeat prostate cancer heterogeneity
15天前
已完结
Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy
15天前
已完结
The Hierarchy of SUVs: From Diagnostics to Therapeutics and the Pathway to Effective Theranostics
15天前
已完结
Navigating the clinical progress of antibody-drug conjugates: Emerging opportunities and remaining challenges
17天前
已完结
皖公网安备34019202002308
